Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

Sadeleştirilmiş öğe sayfası
dc.contributor.authorEsin, E.
dc.contributor.authorOksuzoglu, O. B. Cakmak
dc.contributor.authorBilici, A.
dc.contributor.authorCicin, I.
dc.contributor.authorAksoy, S.
dc.contributor.authorAlacacioglu, A.
dc.contributor.authorKaplan, M. A.
dc.contributor.authorCabuk, D.
dc.contributor.authorSumbul, A. T.
dc.contributor.authorPaydas, S.
dc.contributor.authorSakin, A.
dc.contributor.authorEr, O.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorYildirim, N.
dc.contributor.authorArtac, M.
dc.contributor.authorHarputluoglu, H.
dc.contributor.authorYumuk, P. F.
dc.contributor.authorBasaran, G.
dc.contributor.authorUluc, B. Oyan
dc.contributor.authorDemirci, U.
dc.date.accessioned2025-10-16T15:24:56Z
dc.date.issued2018
dc.description.abstract43rd ESMO Congress (ESMO), Munich, GERMANY, OCT 19-23, 2018
dc.identifier.otherWOS:000459277300323
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8180
dc.publisherOXFORD UNIV PRESS
dc.sourceANNALS OF ONCOLOGY
dc.titlePertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS